uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted January 30, 2018

Limbrel for Osteoarthritis Recalled Due to Risk of Adverse Effects

On January 26, 2018, Primus Pharmaceuticals, Inc. of Scottsdale, Arizona issued a recall of all unexpired lots of Limbrel products. FDA  requested the recall due to rare but serious side effects (which are reversible), including drug-induced liver injury and/or hypersensitivity pneumonitis, associated with the use of Limbrel

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at